Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis

BACKGROUND: Several Canadian provinces have introduced reimbursement policies mandating substitution of innovator biologics with lower-cost biosimilars. We estimated the number of patients affected and cost implications if such policy changes were to be implemented in Ontario, Canada. METHODS: We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Tara, McCormack, Daniel, Kitchen, Sophie A., Paterson, J. Michael, Mamdani, Muhammad M., Proulx, Laurie, Bayliss, Lorraine, Tadrous, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612652/
https://www.ncbi.nlm.nih.gov/pubmed/34815261
http://dx.doi.org/10.9778/cmajo.20210091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612652/
https://www.ncbi.nlm.nih.gov/pubmed/34815261
http://dx.doi.org/10.9778/cmajo.20210091

Ejemplares similares